ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,106Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 288

$610K Total Retail Price of All Prescriptions

Rank: 41 out of 288

376 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 11,661 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
OMEPRAZOLE 687 586 1 3
SIMVASTATIN 641 565 2 1
LEVOTHYROXINE SODIUM 602 509 3 2
LISINOPRIL 561 502 4 4
AMLODIPINE BESYLATE 557 533 5 6
METOPROLOL TARTRATE 439 386 6 8
WARFARIN SODIUM 385 373 7 9
FUROSEMIDE 315 312 8 5
METOPROLOL SUCCINATE 282 271 9 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 202 179 10 34
HYDROCHLOROTHIAZIDE 191 176 11 13
METFORMIN HCL 175 146 12 12
CRESTOR 170 160 13 26
ALENDRONATE SODIUM 166 153 14 20
MIRTAZAPINE 164 136 15 60
METFORMIN HCL ER 152 128 16 76
TAMSULOSIN HCL 149 140 17 24
JANUVIA 148 135 18 88
ATORVASTATIN CALCIUM 142 130 19 14
FINASTERIDE 133 133 20 82
HYDROCODONE-ACETAMINOPHEN 130 126 S3 21 7
LANTUS 125 90 22 31
RISPERIDONE 123 76 23 98
LOSARTAN POTASSIUM 122 104 24 16
CITALOPRAM HBR 117 117 25 18
TRAZODONE HCL 115 88 26 37
AMITRIPTYLINE HCL 115 112 R 26 65
DIOVAN HCT 114 114 28 112
SERTRALINE HCL 106 92 29 25
ACTOS 106 106 29 106
ZETIA 103 103 31 58
ALLOPURINOL 95 95 32 23
GLIPIZIDE ER 87 87 33 93
RANITIDINE HCL 85 61 34 33
POLYETHYLENE GLYCOL 3350 79 68 35 38
CARVEDILOL 79 75 35 27
ROPINIROLE HCL 79 53 35 74
PRAVASTATIN SODIUM 78 78 38 21
CLOPIDOGREL 77 76 39 47
SPIRONOLACTONE 76 76 40 36
NIASPAN 75 63 41 103
POTASSIUM CHLORIDE 75 75 41 11
GLIPIZIDE 73 73 43 56
CYMBALTA 71 71 44 67
DIOVAN 70 70 45 53
DONEPEZIL HCL 70 56 45 29
CEPHALEXIN 70 64 45 83
ISOSORBIDE MONONITRATE ER 69 69 48 35
ATENOLOL 68 68 49 10
BENAZEPRIL HCL 64 64 50 52
IPRATROPIUM BROMIDE 63 54 51 176
PLAVIX 62 62 52 71
LEVETIRACETAM 61 22 53 125
LOVAZA 61 61 53 324
DOXAZOSIN MESYLATE 58 56 55 78
DIGOXIN 58 56 55 51
AMLODIPINE BESYLATE-BENAZEPRIL 58 58 55 89
ADVAIR DISKUS 57 41 58 50
TRAMADOL HCL 57 41 58 19
LEVEMIR FLEXPEN 55 53 60 187
PROAIR HFA 54 47 61 45
AZITHROMYCIN 53 42 62 49
CIPROFLOXACIN HCL 52 37 63 62
HALOPERIDOL 50 31 64 357
BYSTOLIC 50 50 64 96
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 27, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.